Skip to main navigation Skip to search Skip to main content

Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development

  • Douglas Yee
  • , Tufia Haddad
  • , Kathy Albain
  • , Anna Barker
  • , Christopher Benz
  • , Judy Boughey
  • , Meredith Buxton
  • , Amy Jo Chien
  • , Angela DeMichele
  • , David Dilts
  • , Anthony Elias
  • , Paul Haluska
  • , Michael Hogarth
  • , Alan Hu
  • , Nola Hytlon
  • , Henry G Kaplan
  • , Gary G Kelloff
  • , Qamar Khan
  • , Julie Lang
  • , Brian Leyland-Jones
  • Minetta Liu, Rita Nanda, Donald Northfelt, Olufunmilayo I Olopade, John Park, Barbara Parker, David Parkinson, Sonia Pearson-White, Jane Perlmutter, Lajos Pusztai, Fraser Symmans, Hope Rugo, Debu Tripathy, Anne Wallace, David Wholley, Laura Van't Veer, Donald A Berry, Laura Esserman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)4584-6; author reply 4588-9
JournalJournal of Clinical Oncology
Volume30
Issue number36
DOIs
StatePublished - Nov 20 2012

Keywords

  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Breast Neoplasms/therapy
  • Carcinoma in Situ/therapy
  • Carcinoma, Ductal, Breast/therapy
  • Female
  • Humans
  • Mastectomy
  • Neoadjuvant Therapy

Cite this